GILEAD SCIENCES, INC. (GILD) has 17 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 9 sales totalling $13.7M. Most recent filing: Sept. 16, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 16, 2026 filed Sept. 15, 2026 | Dickinson Andrew D Chief Financial Officer | −$435,870 | 3,000 | −2% | Yes | |
|
|
||||||
| Sept. 16, 2026 filed Sept. 15, 2026 | Mercier Johanna Chief Comm & Corp Aff Officer | −$432,646 | 3,000 | −3% | Yes | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 10, 2026 | Dickinson Andrew D Chief Financial Officer | — | +1,450 | +6% | No | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 10, 2026 | Berger Dietmar Chief Medical Officer | — | +270 | +1% | No | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 10, 2026 | Mercier Johanna Chief Comm & Corp Aff Officer | — | +1,450 | +6% | No | |
|
|
||||||
Showing the 5 most recent of 17 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free